| Table 2. The prevalence of metabolic syndrome* and its criteria in adult and adolescent women with polycystic ovary syndrome (PCOS) | ||||
| Criteria | n (total n) - % adolescent PCOS |
n (total n) - % adult PCOS |
P | |
|---|---|---|---|---|
| WC Triglycerides HDL |
≥88 cm ≥150 mg/dl <50 mg/dl |
17 (42) - 40.5% 9 (42) - 21.4% 20 (42) - 47.6% |
76 (105) - 72% 23 (105) - 22% 73 (105) - 69.5% |
0.005 0.82 0.07 |
| BP Fasting Blood Glucose |
≥130x85 mmHg ≥100 mg/dl |
7 (42) - 16.7% 2 (42) - 4.8% |
44 (105) - 42% 18 (105) - 7% |
0.026 0.06 |
| MS Prevalence | ≥3 criteria | 10 (42) - 23.8% | 52 (105) - 49.5% | 0.01 |
WC: Waist Circumference; BP: Blood Pressure; MS: Metabolic Syndrome; PCOS: Polycystic Ovary Syndrome.
*According to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III)14 modified by Association/National Heart15.